DEFINING HEPATOCELLULAR CHIMERISM IN A LIVER FAILURE PATIENT BRIDGED WITH HEPATOCYTE INFUSION 1

Abstract

Bridging liver failure with donor hepatocytes with HLA class I antigen disparate from recipients is clinically feasible, and allows for a marker, combined with serial graft histology, to safely wean immunosuppression when native liver regeneration succeeds.